Ömer Küçük

10.0k total citations
206 papers, 6.8k citations indexed

About

Ömer Küçük is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ömer Küçük has authored 206 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 70 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Ömer Küçük's work include Renal cell carcinoma treatment (34 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Ömer Küçük is often cited by papers focused on Renal cell carcinoma treatment (34 papers), Prostate Cancer Treatment and Research (34 papers) and Bladder and Urothelial Cancer Treatments (28 papers). Ömer Küçük collaborates with scholars based in United States, Türkiye and India. Ömer Küçük's co-authors include Fazlul H. Sarkar, Dong M. Shin, Kazım Şahin, Fadlo R. Khuri, A.R.M. Ruhul Amin, Joanne Davis, Birdal Bilir, Mehmet Tuzcu, Ananda S. Prasad and Nurhan Şahin and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ömer Küçük

199 papers receiving 6.6k citations

Peers

Countries citing papers authored by Ömer Küçük

Since Specialization

Citations

This map shows the geographic impact of Ömer Küçük's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Küçük with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Küçük more than expected).

Fields of papers citing papers by Ömer Küçük

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Küçük. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Küçük. The network helps show where Ömer Küçük may publish in the future.

Co-authorship network of co-authors of Ömer Küçük

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Küçük. A scholar is included among the top collaborators of Ömer Küçük based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Küçük. Ömer Küçük is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation 2024 ·Cancer ·Dylan J. Martini, (unknown), (unknown), Kathryn L. Pellegrini, Elizabeth Beagle, (unknown), (unknown), Bassel Nazha, Jacqueline T. Brown, Shreyas Joshi, Vikram M. Narayan, Kenneth Ogan, Viraj A. Master, Bradley Curtis Carthon, Ömer Küçük, Lara R. Harik, Mehmet Asım Bilen	4
2	The Role of Curcumin in Preventing Naturally Occurring Leiomyoma in the Galline Model 2024 ·Pharmaceuticals ·Kazım Şahin, Cemal Orhan, Mehmet Tuzcu, Nurhan Şahin, İbrahim H. Özercan, Nashwa Kabil, Ömer Küçük, Bülent Özpolat	1
3	Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers 2023 ·Cancer ·Bassel Nazha, (unknown), Sharon Wu, Jacqueline T. Brown, Daniel Magee, Bradley Curtis Carthon, Ömer Küçük, Chadi Nabhan, Pedro C. Barata, Elisabeth I. Heath, Charles J. Ryan, Rana R. McKay, Viraj A. Master, (unknown)	21
4	Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy 2023 ·Clinical Nuclear Medicine ·Ismaheel O. Lawal, Charles Marcus, David M. Schuster, Sharad Goyal, (unknown), Vishal R. Dhere, Shreyas Joshi, (unknown), Viraj A. Master, Pretesh Patel, (unknown), Mark M. Goodman, Joseph W. Shelton, Ömer Küçük, Bruce Hershatter, Raghuveer Halkar, Ashesh B. Jani	6
5	Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT 2022 ·Cancers ·Mehmet Asım Bilen, Akinyemi A. Akintayo, Yuan Liu, (unknown), Ömer Küçük, Bradley Curtis Carthon, David M. Schuster, Ephraim E. Parent	7
6	Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience 2022 ·SHILAP Revista de lepidopterología ·Dylan J. Martini, (unknown), Subir Goyal, Yuan Liu, (unknown), (unknown), (unknown), (unknown), Sarah Caulfield, Jacqueline T. Brown, Jamie Goldman, Bassel Nazha, Bradley Curtis Carthon, Wayne Harris, Ömer Küçük, Viraj A. Master, Mehmet Asım Bilen	1
7	Overcoming prostate cancer drug resistance with a novel organosilicon small molecule 2021 ·Neoplasia ·Rui Zhao, Xiaowei Ma, Lijuan Bai, Xin Li, (unknown), Yang Yang, Hong Yan Liu, (unknown), (unknown), Ömer Küçük, Robert S. Hodges, Lajos Gera, Daqing Wu	7
8	Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database 2021 ·Clinical Genitourinary Cancer ·Karen M. Xu, Yuan Liu, Theresa Gillespie, Adeboye O. Osunkoya, Bradley Curtis Carthon, Mehmet Asım Bilen, Christopher P. Filson, Kenneth Ogan, Pretesh Patel, Joseph W. Shelton, Ömer Küçük, Shreyas Joshi, Ashesh B. Jani	4
9	Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors 2020 ·Cancer Medicine ·Julie M. Shabto, Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, (unknown), (unknown), Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne Harris, Viraj A. Master, Ömer Küçük, Bradley Curtis Carthon, Mehmet Asım Bilen	8
10	Genistein Prevents Development of Spontaneous Ovarian Cancer and Inhibits Tumor Growth in Hen Model 2019 ·Cancer Prevention Research ·Kazım Şahin, (unknown), Birdal Bilir, Cemal Orhan, Mehmet Tuzcu, Nurhan Şahin, İbrahim H. Özercan, Nashwa Kabil, Bülent Özpolat, Ömer Küçük	36
11	Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer 2018 ·Molecular Cancer Therapeutics ·Yang Yang, (unknown), Xin Li, Yanhua Chen, (unknown), Yuhong Du, Haian Fu, Ömer Küçük, Daqing Wu	20
12	Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial 2018 ·Journal of Clinical Oncology ·John J. Coen, Peixin Zhang, Philip J. Saylor, Cheryl T. Lee, Chin‐Lee Wu, William A. Parker, (unknown), Anthony L. Zietman, Jason A. Efstathiou, Ashesh B. Jani, Ömer Küçük, Luís Souhami, Joseph P. Rodgers, Howard M. Sandler, William U. Shipley	97
13	Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial 2018 ·JMIR Research Protocols ·Kerri M. Winters‐Stone, Stacey A. Kenfield, Erin L. Van Blarigan, Esther Moe, Justin Ramsdill, (unknown), (unknown), (unknown), Elizabeth R. Kessler, Ömer Küçük, Theresa Gillespie, Karen S. Lyons, Tomasz M. Beer, Jeanette M. Broering, Peter R. Carroll, June M. Chan	9
14	Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model 2017 ·Cancer Prevention Research ·Kazım Şahin, Cemal Orhan, Mehmet Tuzcu, Nurhan Şahin, Hakkı Taştan, İbrahim Hanifi Özercan, Osman Güler, Nermin Kahraman, Ömer Küçük, Bülent Özpolat	26
15	A Comprehensive Definition for Integrative Oncology 2017 ·JNCI Monographs ·Claudia M. Witt, Lynda G. Balneaves, Maria João Cardoso, Lorenzo Cohen, Heather Greenlee, Peter A.S. Johnstone, Ömer Küçük, Josh Mailman, Jun J. Mao	183
16	Genistein Protects Hematopoietic Stem Cells against G-CSF–Induced DNA Damage 2014 ·Cancer Prevention Research ·(unknown), (unknown), (unknown), Ömer Küçük, Michael R. Rossi, Morgan L. McLemore	10
17	Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition 2012 ·Journal of Biological Chemistry ·Shumin Zhang, Xu Wang, Shareen A. Iqbal, Yanru Wang, Adeboye O. Osunkoya, Zhengjia Chen, Zhuo Chen, Dong M. Shin, Hongwei Yuan, (unknown), Haiyen E. Zhau, Leland W.K. Chung, Chad W.M. Ritenour, Ömer Küçük, Daqing Wu	38
18	A Tomato Lycopene Complex Protects the Kidney From Cisplatin-Induced Injury via Affecting Oxidative Stress as Well as Bax, Bcl-2, and HSPs Expression 2011 ·Nutrition and Cancer ·Ayhan Doğukan, Mehmet Tuzcu, Can Ali Ağca, Hasan Gençoğlu, Nurhan Şahin, Muhittin Önderci, İbrahim Hanifi Özercan, Atilla İlhan, Ömer Küçük, Kazım Şahin	62
19	Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease 2008 ·Respiratory Medicine ·Gamze Kırkıl, Mehmet Hamdi Muz, Dilara Seçkin, Kazım Şahin, Ömer Küçük	42
20	Differential expression of hZnT‐4 in Human prostate tissues 2003 ·The Prostate ·Frances W.J. Beck, Ananda S. Prasad, Charles E. Butler, Wael Sakr, Ömer Küçük, Fazlul H. Sarkar	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact